1
A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection
Condition(s): Graft Rejection Last Updated: November 16, 2012Recruiting
31 Clinical Trials for: C1 Esterase Inhibitor Human, Page 1 of 2
Hide Studies Not Seeking New Volunteers
2
A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase
Condition(s): Hereditary Angioedema Last Updated: November 30, 2012Completed
3
Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks
Condition(s): Hereditary Angioedema Last Updated: March 19, 2013Recruiting
4
In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia - VECTOR II
Condition(s): Innate Immune Response; Endotoxemia; Inflammation; Sepsis Last Updated: January 9, 2013Not yet recruiting
5
In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia
Condition(s): Endotoxemia; Inflammation; Multi Organ Dysfunction Syndrome Last Updated: April 21, 2011Completed
6
C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks
Condition(s): Hereditary Angioedema Last Updated: June 16, 2010Completed
7
C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks
Condition(s): Hereditary Angioedema Last Updated: June 16, 2010Completed
8
Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks
Condition(s): Hereditary Angioedema Last Updated: June 16, 2010Completed
9
Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks
Condition(s): Hereditary Angioedema Last Updated: May 7, 2010Completed
10
Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks
Condition(s): Hereditary Angioedema Last Updated: February 10, 2011Completed
11
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
Condition(s): Hereditary Angioedema; C1 Esterase Inhibitor Deficiency Last Updated: May 9, 2012Active, not recruiting
12
Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects
Condition(s): Hereditary Angioedema Last Updated: March 17, 2010Completed
13
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
Condition(s): Hereditary Angioedema; Angioneurotic Edema Last Updated: February 20, 2013Completed
14
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
Condition(s): Hereditary Angioedema; Angioneurotic Edema; Genetic Disorders Last Updated: September 27, 2012Completed
15
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
Condition(s): Genetic Disorders Last Updated: February 21, 2013Completed
16
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
Condition(s): Genetic Disorders Last Updated: April 24, 2013Completed
17
C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study)
Condition(s): Hereditary Angioedema Last Updated: October 6, 2011Completed
18
A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route
Condition(s): Hereditary Angioedema Types I and II Last Updated: January 17, 2013Completed
19
Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks
Condition(s): Hereditary Angioedema Last Updated: February 20, 2013Active, not recruiting
20
Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation
Condition(s): Graft Rejection; Kidney Transplantation Last Updated: February 15, 2012Withdrawn
